financetom
Business
financetom
/
Business
/
US allows flyers to travel with drug derived from marijuana
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US allows flyers to travel with drug derived from marijuana
May 29, 2019 2:50 AM

The Transportation Security Administration has changed its cannabis policy to allow passengers to travel with some forms of CBD oil and a drug derived from marijuana that has been approved by the Food and Drug Administration.

All forms of marijuana were previously prohibited in carry-on bags and checked luggage. On Sunday, TSA updated its "What Can I bring?" guidance under medical marijuana. The FDA in June legalized a drug called Epidiolex, which is used to treat epilepsy in children. The TSA said in a statement that it was recently made aware of the drug and updated the regulations to avoid confusion on whether families can bring it when travelling.

The new policy also includes some CBD oil, "as long as it is produced within the regulations defined by the law" under the 2018 Farm Bill, which legalized hemp and hemp derivatives. Hemp-derived CBD is low in or has no THC, the chemical that produces a high found in marijuana.

The TSA's new rules still ban other forms of marijuana, including CBD oils that have THC, and cannabis-infused products that are still illegal under federal law.

It's not clear how agents will determine the difference. But while agents screen for potential threats to planes and passengers, they do not search for marijuana or other illegal drugs. If they come across anything suspect, they refer it to law enforcement.

The change in TSA's cannabis policy was first reported by Marijuana Moment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Platinum Equity's Ingram Micro raises $233 mln in US IPO
Platinum Equity's Ingram Micro raises $233 mln in US IPO
Oct 24, 2024
Oct 23 (Reuters) - Ingram Micro priced its U.S. initial public offering at $22 per share, within its targeted range of $20 and $23 on Wednesday, raising $233.1 million, the technology distributor said. ...
Chinese self-driving startup WeRide files for $119 mln U.S. IPO
Chinese self-driving startup WeRide files for $119 mln U.S. IPO
Oct 24, 2024
Oct 23 (Reuters) - Chinese self-driving startup WeRide has filed for a $119.4 million initial public offering on Nasdaq and a private placement of $320.5 million, according to a term sheet seen by Reuters on Wednesday. As part of the offering, the Guangzhou-based company will offer 6.5 million American depositary shares in a price range of $15.5 to $18.5 apiece,...
BRIEF-Oaktree Acquisition Corp. Iii Life Sciences Prices $175 mln Initial Public Offering At $10.00 Per Unit
BRIEF-Oaktree Acquisition Corp. Iii Life Sciences Prices $175 mln Initial Public Offering At $10.00 Per Unit
Oct 24, 2024
Oct 23 (Reuters) - Oaktree Acquisition Corp III ( OACCU ) : * OAKTREE ACQUISITION CORP. III LIFE SCIENCES ANNOUNCES PRICING OF $175 MILLION INITIAL PUBLIC OFFERING * OAKTREE ACQUISITION CORP III ( OACCU ) - PRICED ITS IPO OF 17.5 MILLION UNITS AT A PRICE OF $10.00 PER UNIT Source text for Eikon: Further company coverage: ...
Platinum Equity's Ingram Micro to raise about $409 mln in US IPO
Platinum Equity's Ingram Micro to raise about $409 mln in US IPO
Oct 24, 2024
Oct 23 (Reuters) - Ingram Micro priced its U.S. initial public offering at $22 per share, within its targeted range of $20 and $23 on Wednesday, raising $409.2 million, the technology distributor said. Ingram Micro and its private equity owner, Platinum Equity, sold 18.6 million shares at $22 each. The IPO valued the Irvine, California-based company at around $5.18 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved